文献速递神经肿瘤

3000余例脑膜瘤基因组亚组与临床特征的相关性

Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
PubMed 文献 · J Neurosurg · 2019-10-25

该研究对多机构3016例脑膜瘤进行已知驱动基因靶向测序并划分互斥基因组亚组,分析其与临床特征的关系。结果显示基因组亚组与肿瘤位置、性别、组织学及瘤周水肿等特征显著相关,机器学习模型基于无创临床特征对驱动突变具有中等预测价值。

要点

  • HH亚组肿瘤与中线位置相关,非NF2肿瘤见于前颅底区域。
  • NF2脑膜瘤在男性中显著富集,KLF4与POLR2A突变与女性相关。
  • KLF4突变者瘤周脑水肿更大,SMARCB1病例Ki-67指数升高。

核心结论

  • 基因组亚组与脑膜瘤位置、性别、组织学及影像特征显著相关,扩展了既往发现。

研究设计与样本

  • 多机构3016例脑膜瘤进行已知驱动基因靶向测序,划分互斥基因组亚组并关联临床信息。

主要发现

  • HH肿瘤与中线位置相关,非NF2肿瘤见于前颅底区域。
  • NF2脑膜瘤在男性中显著富集,KLF4和POLR2A突变与女性相关。
  • KLF4突变者瘤周脑水肿更大,SMARCB1病例Ki-67指数升高。
  • 「突变未知」样本中微囊特征富集。
  • 机器学习显示无创临床特征对驱动突变有中等预测价值。

临床怎么用

  • 无创临床特征可辅助预测脑膜瘤基因组亚组,有望减少侵入性采样。

局限性

  • 无创变量预测价值为中等,需更多训练数据提升。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Recent large-cohort sequencing studies have investigated the genomic landscape of meningiomas, identifying somatic coding alterations in NF2, SMARCB1, SMARCE1, TRAF7, KLF4, POLR2A, BAP1, and members of the PI3K and Hedgehog signaling pathways. Initial associations between clinical features and genomic subgroups have been described, including location, grade, and histology. However, further investigation using an expanded collection of samples is needed to confirm previous findings, as well as elucidate relationships not evident in smaller discovery cohorts. METHODS: Targeted sequencing of established meningioma driver genes was performed on a multiinstitution cohort of 3016 meningiomas for classification into mutually exclusive subgroups. Relevant clinical information was collected for all available cases and correlated with genomic subgroup. Nominal variables were analyzed using Fisher's exact tests, while ordinal and continuous variables were assessed using Kruskal-Wallis and 1-way ANOVA tests, respectively. Machine-learning approaches were used to predict genomic subgroup based on noninvasive clinical features. RESULTS: Genomic subgroups were strongly associated with tumor locations, including correlation of HH tumors with midline location, and non-NF2 tumors in anterior skull base regions. NF2 meningiomas were significantly enriched in male patients, while KLF4 and POLR2A mutations were associated with female sex. Among histologies, the results confirmed previously identified relationships, and observed enrichment of microcystic features among "mutation unknown" samples. Additionally, KLF4-mutant meningiomas were associated with larger peritumoral brain edema, while SMARCB1 cases exhibited elevated Ki-67 index. Machine-learning methods revealed that observable, noninvasive patient features were largely predictive of each tumor's underlying driver mutation. CONCLUSIONS: Using a rigorous and comprehensive approach, this study expands previously described correlations between genomic drivers and clinical features, enhancing our understanding of meningioma pathogenesis, and laying further groundwork for the use of targeted therapies. Importantly, the authors found that noninvasive patient variables exhibited a moderate predictive value of underlying genomic subgroup, which could improve with additional training data. With continued development, this framework may enable selection of appropriate precision medications without the need for invasive sampling procedures.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Youngblood MW, Duran D, Montejo JD, et al. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas. J Neurosurg. 2019. PMID: 31653806. doi:10.3171/2019.8.JNS191266

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。